These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 355033

  • 21. Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.
    Lageder H, Irsigler K.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):71-5. PubMed ID: 798199
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A, Foradori A, Eyzaguirre J, Lira P, Vasquez A, Soto S, Alliende ME, Guzman L.
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract] [Full Text] [Related]

  • 23. [Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
    Stähelin HB, Hartmann G.
    Dtsch Med Wochenschr; 1974 Jun 28; 99(26):1392-4 passim. PubMed ID: 4601124
    [No Abstract] [Full Text] [Related]

  • 24. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H.
    Med Klin; 1979 Jun 01; 74(22):875-6. PubMed ID: 470785
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Wolf HR.
    Drugs Exp Clin Res; 1994 Jun 01; 20(3):109-13. PubMed ID: 7956717
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P, Motolese M, Cerqua R, Mancini M.
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct 01; 2(4):348-53. PubMed ID: 4903988
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Changes in the lipid profiles of hyperlipemic patients treated with binifibrate].
    Avellaneda A, Rueda A, Cascio C, Gutiérrez JA.
    An Med Interna; 1993 Jun 01; 10(6):275-9. PubMed ID: 8334204
    [Abstract] [Full Text] [Related]

  • 32. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
    Sterner W, Schultz A.
    Arzneimittelforschung; 1974 Dec 01; 24(12):1990-2. PubMed ID: 4480360
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [A double-blind clinical trial--the effects of pantethine on serum lipids in patients with hyperlipidemia].
    Lu ZL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug 01; 17(4):221-3. PubMed ID: 2697544
    [No Abstract] [Full Text] [Related]

  • 38. [Design and evaluation of the controlled clinical trial/demonstrated by an efficacy test of the combination pentosan polysulphate/nicotinic acid in disturbed cerebral circulation (author's transl)].
    Loos M, Rahlfs VW.
    Arzneimittelforschung; 1976 Apr 01; 26(4):584-91. PubMed ID: 782468
    [Abstract] [Full Text] [Related]

  • 39. The effect of n - 3 PUFA/gamma-cyclodextrin complex on serum lipids in healthy volunteers--a randomized, placebo-controlled, double-blind trial.
    Kobayashi K, Hamazaki K, Fujioka S, Terao K, Yamamoto J, Kobayashi S.
    Asia Pac J Clin Nutr; 2007 Apr 01; 16(3):429-34. PubMed ID: 17704023
    [Abstract] [Full Text] [Related]

  • 40. [Evaluation of efficacy and safety of etofibrate in primary hyperlipidemia. A multicenter study].
    dos Santos JE, Loures-Vale AA, Novazzi JP, Rabelo LM, Martinez TL.
    Arq Bras Cardiol; 1996 Dec 01; 67(6):419-22. PubMed ID: 9246832
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.